| CYSB2000273 | 冻干静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Lyophilized | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CYSB2000272 | 冻干静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Lyophilized | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CYSB2000276 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CYSB2000274 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CXSB2100004 | 冻干静注乙型肝炎人免疫球蛋白（pH4） | human hepatitis B immunoglobulin(pH4) | Lyophilized | Biological Products | Supplementary Application | 2021-01-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-08 | view |
| CXSS1900039 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2019-11-08 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-09-08 | view |
| CXSS1900037 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2019-10-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-23 | view |
| CXSL2000371 | 皮下注射人免疫球蛋白（注射液） | | Injection | Biological Products(2.1) | New Drug Application | 2020-12-23 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2020-12-21 | view |
| CYSB2000275 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2020-11-10 | view |
| CXSL2000306 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products(2.4) | New Drug Application | 2020-10-28 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2020-10-27 | view |
| CYSB1900269 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2019-07-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2019-09-26 | view |
| CYSB1900268 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2019-07-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2019-09-26 | view |
| CYSB1900011 | 静注人免疫球蛋白（pH4、10%）（层析法） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2019-01-26 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2019-01-23 | view |
| CXSS1700007 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products(15) | New Drug Application | 2017-05-16 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2019-01-17 | view |
| CXSL1700171 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products(15) | New Drug Application | 2018-03-08 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2018-10-23 | view |
| CXSS1600011 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2017-02-22 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2018-05-24 | view |
| CXSL1700070 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2017-08-16 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2018-05-08 | view |
| CXSL1600037 | 静注巨细胞病毒人免疫球蛋白 | | Other | Biological Products(7) | New Drug Application | 2016-06-12 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1600038 | 静注巨细胞病毒人免疫球蛋白(pH4) | | Other | Biological Products(7) | New Drug Application | 2016-06-12 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1500059 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products(15) | New Drug Application | 2015-09-16 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-11-17 | view |
